Emory Molecular and Translational Imaging Center

在创建埃默里分子和翻译成像中心（EMTIC），我们已经建立在一个独特的支持亚特兰大生物医学环境，在埃默里大学和技术（格鲁吉亚技术）的格鲁吉亚研究所蓬勃发展的成像研究社区，和显着增长的温希普癌症研究所。EMTIC的愿景和使命是一个跨学科的科学，行政和教育网络，包括成像科学家和基础和临床科学家在癌症诊断和治疗的重要领域工作。正如设想的那样，EMTIC是多方面的连接器，连接学科，加速创新方法的发展，并促进其快速临床翻译。这一使命至关重要，EMTIC与埃默里大学和格鲁吉亚理工学院在成像技术、生物标志物开发、预测和个性化医学以及纳米技术方面的战略和转型投资密切相关。 分子成像癌症生物标志物的开发和验证的进展将建立在三个主要研究项目，四个专业资源（核心），发展基金的投资，以支持试点项目和重点职业发展组成部分的结构。研究项目包括（项目#1）前列腺癌的转化研究 使用[[18]F]FACBC的患者，这是埃默里大学开发的一种氨基酸转运蛋白配体，也是我们研究团队从实验室到床边能力的一个例子。项目#2将开发和验证头颈癌中的选择性趋化因子PET标记物。在项目#3中，我们将在乳腺癌动物模型中评估一种独特的靶向特异性分子MRI探针。项目#4测试了一种新型近红外（NIR）荧光染料在前列腺癌中的应用。成像（核心A），示踪剂开发（核心B），生物统计学，建模和数据管理（核心C）以及动物，病理学和肿瘤模型（核心D）的专业资源将为研究项目以及第一年和未来的试点项目提供支持。EMTIC还将为支持综合职业发展计划提供理想的结构，以使未来的成像科学家具备跨学科的能力。 技术和翻译技能，专门从事癌症护理的细胞和分子成像。

In creating the Emory Molecular and Translational Imaging Center (EMTIC), we have built upon a uniquely supportive Atlanta biomedical environment, a flourishing imaging research community across Emory University and the Georgia Institute of Technology (Georgia Tech), and remarkable growth of the Winship Cancer Institute. The vision and mission for EMTIC is a cross-disciplinary scientific, administrative, and educational network that encompasses imaging scientists and basic and clinician scientists working in areas vital to cancer diagnosis and therapeutics. As conceived, EMTIC is the multi-faceted connector that joins disciplines to accelerate innovative methodological developments and foster their rapid clinical translation. Vital to this mission, EMTIC is closely .aligned with strategic and transforming investments in imaging technology, biomarker development, predictive and personalized medicine, and nanotechnology based at Emory and Georgia Tech. Progress in the development and validation of molecular imaging cancer biomarkers will be founded in a structure of three major Research Projects, four Specialized Resources (Cores), investment in Developmental Funds to support Pilot projects, and a focused Career Development Component. The Research Projects include (Project #1) a translational study of prostate cancer patients using [[18]F]FACBC, an amino acid transporter ligand developed at Emory and an example of the bench-to-bedside capabilities of our investigative team. Project #2 will develop and validate selective chemokine PET markers in head and neck cancer. In Project #3 we will evaluate a unique target-specific molecular MRI probe in a breast cancer animal model. Project #4 tests a novel near-infrared (NIR) fluorescent dye in prostate cancer. Specialized Resources for Imaging (Core A), Tracer Development (Core B), Biostatistics, Modeling, and Data Management (Core C), and Animals, Pathology, and Tumor Models (Core D) will provide support for the Research Projects as well as Year 1 and future Pilot Projects. EMTIC will also provide an ideal structure for support of an integrated Career Development Program to equip the future imaging scientist with the interdisciplinary technical and translational skills to specialize in cellular and molecular imaging for cancer care.